Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years

Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years

Ohio State University researchers have evidence that blood samples can reliably detect fibromyalgia, a disease that is often misdiagnosed due to its general symptoms that characterize a number of other conditions.

Shutterstock | pathdoc

Published in the Journal of Biological Chemistry, the study describes success in finding biomarkers of fibromyalgia and distinguishing the disease from other, related conditions. The study describes the diagnosis and treatment of fibromyalgia as a “challenge owing to the lack of reliable biomarkers.”

Fibromyalgia is a long-term condition that causes body-wide pain. Other symptoms of fibromyalgia include increase sensitivity to pain, fatigue, stiff muscles, disturbed sleep, irritable bowel syndrome, and cognitive disturbances such as problems with memory and concentration. There is currently no cure for fibromyalgia, so treatment consists of medication, talking therapies, and lifestyle changes to help relieve and manage symptoms of the condition.

Diagnosing fibromyalgia relies on a wide range of symptoms reported by the patients themselves. Diagnosis also sometimes includes a physical evaluation of a patient’s pain by applying light pressure to specific tender points where pain is often felt. But diagnostic tools are lacking quick and accessible options to definitively diagnose fibromyalgia.

Carried out by The Ohio State University, the objective of the study was to develop a “rapid biomarker-based method for diagnosing fibrmyalgia by using vibrational spectroscopy to differentiate patients with fibromyalgia from those with rheumatoid arthritis, osteoarthritis, or systemic lupus erythematosus”. The research also aimed to identify metabolites “associated with these differences.”

The discoveries coming from the study could significantly improve patient care. Lead researcher Kevin Hackshaw, who is a professor in Ohio State’s College of Medicine and a rheumatologist at the Wexner Medical Center, described how patients are often left without proper care or advice on how to manage the chronic pain and fatigue caused by FM.

But, a “metabolic fingerprint”, or biomarkers of the disease like the ones found in this study, could be identified and used to create targeted treatment for patients. Hackshaw said:

“We found clear, reproducible metabolic patterns in the blood of dozens of patients with fibromyalgia. This brings us much closer to a blood test than we have ever been.”

Co-author of the study Luis Rodriguez-Saona said:

“We can look back into some of these fingerprints and potentially identify some of the chemicals associated with the differences we are seeing.”

“This could lead to better, more directed treatment for patients,” Hackshaw said.

In time, a particular protein, acid, or combination of molecules could be identified that is associated with fibromyalgia. Additionally, metabolic fingerprinting could even assess the severity of the condition in each patient.

With patients sometimes waiting an average of five years between the development of symptoms and final diagnosis, fast, accurate diagnosis is desperately needed, and has a number of clear benefits for patients and doctors alike. Patients can be assured that their symptoms are real and not imagined, and doctors can make faster and more confident diagnoses and can curate appropriate and informed treatment plans.

Patients that are left undiagnosed are often given strong and addictive opioid painkillers that have not produced evidence of being an effective treatment for those with fibromyalgia.

Hackshaw states, “When you look at chronic pain clinics, about 40 percent of patients on opioids meet the diagnostic criteria for fibromyalgia. Fibromyalgia often gets worse, and certainly doesn’t get better, with opioids.”

Unfortunately, some medical professionals are also in doubt about the validity of fibromyalgia as a disease. “Most physicians nowadays don’t question whether fibromyalgia is real, but there are still skeptics out there,” Hackshaw explains.

To build on the findings of the study, Hackshaw and Rodriguez-Saona aim to carry out larger-scale clinical trials to see if the results produced by this study can be reliably replicated.

This study included 50 participants with a fibromyalgia diagnosis. Also included in the study were 29 people with rheumatoid arthritis, 23 people with lupus, and 19 people with osteoarthritis.

Blood samples from each participant were analyzed using vibrational spectroscopy, a technique used to measure the energy level of molecules. This technique showed up definite patterns that distinguished the blood samples of fibromyalgia patients from the samples of the other participants living with different, but symptomatically similar, conditions.

Baseline patterns were generated from samples taken from patients whose disease status they were aware of before using two types of spectroscopy to evaluate the remaining samples. Although the researchers did not know the participants’ diagnoses for the remaining samples, they were able to accurately group every sample into disease categories based on the sample’s molecular signature.

Rodriguez-Saona is an expert in the testing methods used in the study. His lab utilizes metabolic fingerprinting for research in food, investigating issues including the adulteration of milk and cooking oils, and works to help agricultural organizations to identify plants that are well suited to combat disease.

Rodriguez-Saona said on the impact of this new study’s discovery:

“These initial results are remarkable. If we can help speed diagnosis for these patients, their treatment will be better and they’ll likely have better outlooks. There’s nothing worse than being in a gray area where you don’t know what disease you have.”

The study concludes that vibrational spectroscopy “may provide a reliable diagnostic test” for differentiating fibromyalgia from other conditions, and Hackshaw hopes that there will be a test available for broad clinical use within five years.

Tagged with:

About author

Related Articles